EntryPoint Capital, LLC

SEC CIK: 0001992519
Latest filing: Aug 13, 2026

SEC filings (opens in a new tab)

DAWN holding history

Day One Biopharmaceuticals, Inc. in every 13F filed by EntryPoint Capital, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

DAWN overview All 13F holders of DAWN Full Q2 2026 holdings

Shares (Q4 2024): 0; Sold out in Q4 2024
Value: $0
% of portfolio: 0.0%
Quarters held: 3; Since Q1 2024

Holdings of DAWN by EntryPoint Capital, LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q4 2024	0	$0	0.0%	−29,254−100.0%	Sold out	Holders
Q3 2024	29,254	$407.5K	0.2%	+451+1.6%	Added	Holders
Q2 2024	28,803	$396.9K	0.2%	+28,221+4,849.0%	Added	Holders
Q1 2024	582	$9.62K	<0.1%	+582	New	Holders